Part of $1 Billion Investment Strategy, PCI Pharma Services Completes Acquisition of Ajinomoto Althea, Enhancing US Drug Product Manufacturing for Aseptic Filling of Prefilled Syringes & Cartridges
PCI Pharma Services ('PCI') – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies – has completed its acquisition of Ajinomoto Althea, Inc. ('Althea'), a US-based sterile fill-finish CDMO and subsidiary of Japan-based Ajinomoto Co., Inc. For PCI, the acquisition is a cornerstone of a multi-year investment strategy spanning facilities in the United States and Europe. In the United States, Althea's assets combine with PCI's existing sterile fill-finish and advanced drug delivery operations to form a world-class, large-scale manufacturing hub in San Diego, complete with state-of-the-art large-scale aseptic facilities for prefilled syringes and cartridges. Among other categories, Althea's campus specializes in customized, scalable oligonucleotides and peptides, supporting PCI's existing manufacturing of complex formulations and lyophilization for a broad range of injectables – including nanoparticles, mRNA, MABs, proteins and other biologics.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250501652991/en/
PCI Pharma Services enhances US manufacturing of prefilled syringes & cartridges through acquisition of Ajinomoto Althea.
Additional information regarding this acquisition is available at a dedicated webpage on PCI's website.
The acquisition also adds high potent vial filling with lyophilization, expanding PCI's sterile fill-finish capacity and serving as an expedient entrée into the rapidly emerging oncology modality of high potent antibody-drug conjugates (ADCs). In fact, the move places PCI among the few US-based CDMOs capable of filling ADCs – a category the company initially began building toward earlier this year, with a sophisticated new pharmaceutical development lab for potent and non-potent compounds at its manufacturing Center of Excellence in Bedford, NH. The Bedford sterile fill-finish expansion strategy started with a large investment in a purpose-built facility featuring twin lyophilizers and a state-of-the-art large-scale isolator filling line compliant with Annex 1. That facility will be GMP ready this summer; since the plant's 2022 groundbreaking, PCI has methodically developed aseptic-by-design processes as part of its commitment to providing fully isolated high-volume vial filling and lyophilization solutions.
Considering this, the acquisition is a natural next step in PCI's evolution in advanced drug delivery systems like prefilled syringes, cartridges and autoinjectors. Last year, PCI announced investments exceeding $365 million to support the clinical- and commercial-scale final assembly and packaging of drug-device combination products utilizing advanced delivery systems, with an emphasis on injectable formats. Comprising new and expanded infrastructure in both the United States and Europe, the effort bolsters PCI's ability to manage the full lifespan of DDCs, from sterile drug product development and manufacturing through clinical trial supply, product launch and commercialization.
In the United States, the investment includes two new large-scale facilities at PCI's Rockford, Illinois campus. Building upon the company's successful Philadelphia Biotech Center of Excellence, the facilities will house over 25 dedicated suites with high-speed, multiformat lines for clinical- and commercial-scale assembly and packaging of prefilled syringes, autoinjectors, vials and pen-cartridge combinations, and incorporate extensive ISO-standard product testing capabilities and premium top-load cartoning technology. The campus also comprises capabilities for low- to medium-volume DDC assembly and packaging. Both facilities will be GMP ready in fall 2025.
In Europe, PCI recently acquired a packaging and device assembly facility in Dundalk, Ireland, which provides commercial-scale operations for injectables and oral solid dose products. At its City North Dublin campus, PCI also expanded and constructed a 120,000-sq-ft packaging and device assembly services facility, which is slated to commence operations in summer 2025.
Elsewhere in Europe, as part of an additional $25 million investment in its Leon, Spain facility, PCI is currently incorporating a sophisticated new high-speed filling line for syringes and cartridges. Equipped with isolator technology, the automated line delivers unsurpassed flexibility and reliability for biopharma customers. The effort also includes a recently completed state-of-the-art biologics development lab, further enhancing PCI's upstream capabilities.
Assisted by the Althea acquisition, PCI's goal is to be among the first CDMOs to bring the whole lifespan of advanced drug delivery and drug-device combination products under one corporate roof – a journey spanning PCI's clinical trial supply network with cold chain storage solutions straight through launch and commercialization.
'Our pharma customers and the healthcare personnel and patients they serve are the heartbeat behind each stride we've made throughout this ambitious investment plan in sterile fill-finish and advanced drug delivery solutions,' said Salim Haffar, CEO of PCI Pharma Services. 'Concerning this latest step, Ajinomoto Althea enjoys a longstanding, well-earned reputation for producing novel biologics in various injectable formats. Welcoming Althea's talented professionals into the PCI family strengthens our commitment to turnkey customer partnerships and, ultimately, our dedication to helping improve patient outcomes through life-changing therapies.'
About PCI Pharma Services
PCI is a world-leading CDMO, providing clients with integrated end-to-end drug development, manufacturing and packaging capabilities that increase their products' speed to market and opportunities for commercial success. PCI brings the proven experience that comes with more than 90 successful product launches each year and over five decades in the healthcare services business. The company currently has 35 sites across seven countries (United States, Canada, United Kingdom, Ireland, Germany, Spain and Australia), and over 8,000 employees working to bring life-changing therapies to patients.
Leading technology and continued investment enable PCI Pharma Services to address global drug development needs throughout the entire product life cycle – from manufacturing capabilities through the clinical trial supply chain and commercialization. Its clients utilize PCI as an extension of their business, and a collaborative partner with the shared goal of improving patients' lives. For more information, visit pci.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250501652991/en/
PCI Pharma Services
Christopher Dale, Turchette Agency
(973) 227-8080, ext. 116; cdale@turchette.com
© Business Wire, Inc.
Aviso legal :
Este comunicado de imprensa não é um documento produzido pela AFP. A AFP não será responsável por este conteúdo. Para mais informações, por favor entre em contato com as pessoas ou entidades mencionadas no comunicado.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fashion Network
an hour ago
- Fashion Network
Polimoda director Massimiliano Giornetti says the new generation of designers shows greater resilience
Since February 2021, Massimiliano Giornetti has led Polimoda, the Florence-based fashion school where he once earned his degree in collaboration with the London College of Fashion. He returned to the school in 2019 as head of fashion design. Alongside his academic career, Giornetti built a distinguished track record in luxury fashion. He directed Salvatore Ferragamo 's creative vision for 16 years, first in menswear, then in womenswear and accessories. He also served as design director at the Chinese luxury house Shanghai Tang. Giornetti spoke with about how young designers and their aspirations have evolved in recent years. How has creativity evolved in recent years? Massimiliano Giornetti: Creativity today is increasingly free and independent. The new generation of designers is moving away from the standardization that once dominated the industry. They are more drawn to niche concepts and independent thinking. FNW: What explains this new approach? MG: Young designers clearly reject overconsumption and the accelerated pace that has driven the fashion and luxury markets in recent years. Fashion now leans toward extreme luxury, and very few consumers can afford products from major brands. Our students align more closely with emerging consumer behaviors that favor slower consumption and a more mindful approach to spending. You can even see it in how they dress. They choose vintage and independent designs over logos. They increasingly question the constant turnover of creative directors at luxury houses, watching brands celebrate designers one season and dismiss them the next. FNW: What do emerging designers want today? MG: Emerging designers define success by their ability to express their point of view to their community, not by wealth. They show little interest in pursuing creative director roles compared to previous generations. Instead, they focus on building their own brands with unique content and a personal voice. They create independent projects that connect with smaller, more engaged communities that value their creative vision. FNW: But in today's market, it is very difficult to stand out… MG: The market is challenging, but young designers have a real opportunity. The desire to express oneself through clothing runs deep in human nature. Young consumers use fashion to convey both aesthetic and ethical values. They also buy less from major houses, as those brands operate in the ultra-luxury segment with increasingly prohibitive prices. This shift creates space for new generations of designers. They have a chance to stand out. MG: Today's young designers bring incredible eclecticism and agility. They move seamlessly between two-dimensional and three-dimensional design. They approach their creative process in a highly hands-on way. This generation shows much greater resilience than mine and collaborates far more effectively than in the past.
Fashion Network
an hour ago
- Fashion Network
French lingerie brand Ysé opens first London boutique
French lingerie label Ysé is continuing its international expansion. The Paris-based brand, founded in 2012 by Clara Blocman and majority-owned by the Etam group, opened its first UK boutique on May 15 at 190 King's Road in London's South Kensington. Known for its chic and comfortable lingerie, Ysé is growing rapidly, reporting 40% annual sales growth as it pursues a targeted retail strategy in key markets. 'After Paris, London is the second city where our online customers are based. It is a global city, with many French residents. However, we needed to establish the brand firmly before expanding to the UK. Brexit complicated the process, and good locations remain rare and expensive,' says Blocman. The presence of other French brands, including Sœur, Balibaris, and Oh My Cream!, also influenced her decision. 'We are very pleased with the boutique's early performance, which is attracting both destination customers and passersby.' Ysé opened its first store outside France in Brussels last year. Rather than targeting a new country next, the brand plans to add a second location in London. The United States remains a key online market, ahead of Italy, Spain, and Germany. Headquartered in Paris' ninth arrondissement, Ysé has two additional openings planned for 2025. It recently opened a store in Rennes at 4 rue de Toulouse, where it is testing a new concept focused on circularity. 'We see this as an educational store, featuring our first in-store second-hand section, offering only Ysé pieces. It also helps raise awareness about lingerie care and repair,' says Blocman. In early July, Ysé will add a new Paris location to its existing six stores in the capital. The new boutique will open on Rue Bonaparte in Saint-Germain-des-Prés, marking the brand's first standalone store on the Left Bank, where it already operates a corner at Le Bon Marché. The company now operates 20 points of sale, including two corners. An HEC graduate, Blocman remains independent in her strategic decisions while benefiting from synergies with the Etam group. Logistics are managed through a shared warehouse, and the group also supports Ysé in negotiating and securing retail locations. Certified B Corp in 2024, Ysé reports that 95% of its products meet its responsibility standards, with materials either made in France or sourced from certified or recycled fibers. The brand focuses on local sourcing, with production concentrated in Morocco, Tunisia, Portugal, and Italy. Originally designed for smaller busts, Ysé has expanded its size range to include up to an E cup and launched ready-to-wear in 2020, maintaining its delicate, creative style. 'We balance scarcity—to maintain desirability—with careful stock forecasting to avoid unnecessary frustration. We have faced some very fast stockouts, so we now aim for more restocking,' says Blocman. A fan of collaborations, Ysé—whose customers have an average age of 33—has renewed its partnership with maternity brand Tajine Banane this season. The brand is also launching a new collaboration with Grasse-based perfumer Fragonard for its swimwear line, which evokes the Mediterranean through swimsuits, pareos, and quilted bags. After achieving 40% growth in 2024, the 150-employee company expects similar growth in 2025 in what Blocman describes as 'a highly fragmented and competitive market.' From €15.5 million in revenue reported in 2023, Ysé could surpass the €30 million mark this year, with more than 50% of sales generated online. 'We are also seeing growth on a like-for-like basis,' emphasizes Blocman. 'We've benefited from stronger brand awareness over the past two years and improved store traffic,' she adds. The brand also focuses on personal service. 'Our best customers appreciate advice. The human element is very important, which is why we are opening boutiques. Our approach is omnichannel, and it will remain so.'
Fashion Network
2 hours ago
- Fashion Network
Polimoda director Massimiliano Giornetti says the new generation of designers shows greater resilience
Since February 2021, Massimiliano Giornetti has led Polimoda, the Florence-based fashion school where he once earned his degree in collaboration with the London College of Fashion. He returned to the school in 2019 as head of fashion design. Alongside his academic career, Giornetti built a distinguished track record in luxury fashion. He directed Salvatore Ferragamo 's creative vision for 16 years, first in menswear, then in womenswear and accessories. He also served as design director at the Chinese luxury house Shanghai Tang. Giornetti spoke with about how young designers and their aspirations have evolved in recent years. How has creativity evolved in recent years? Massimiliano Giornetti: Creativity today is increasingly free and independent. The new generation of designers is moving away from the standardization that once dominated the industry. They are more drawn to niche concepts and independent thinking. FNW: What explains this new approach? MG: Young designers clearly reject overconsumption and the accelerated pace that has driven the fashion and luxury markets in recent years. Fashion now leans toward extreme luxury, and very few consumers can afford products from major brands. Our students align more closely with emerging consumer behaviors that favor slower consumption and a more mindful approach to spending. You can even see it in how they dress. They choose vintage and independent designs over logos. They increasingly question the constant turnover of creative directors at luxury houses, watching brands celebrate designers one season and dismiss them the next. FNW: What do emerging designers want today? MG: Emerging designers define success by their ability to express their point of view to their community, not by wealth. They show little interest in pursuing creative director roles compared to previous generations. Instead, they focus on building their own brands with unique content and a personal voice. They create independent projects that connect with smaller, more engaged communities that value their creative vision. FNW: But in today's market, it is very difficult to stand out… MG: The market is challenging, but young designers have a real opportunity. The desire to express oneself through clothing runs deep in human nature. Young consumers use fashion to convey both aesthetic and ethical values. They also buy less from major houses, as those brands operate in the ultra-luxury segment with increasingly prohibitive prices. This shift creates space for new generations of designers. They have a chance to stand out. MG: Today's young designers bring incredible eclecticism and agility. They move seamlessly between two-dimensional and three-dimensional design. They approach their creative process in a highly hands-on way. This generation shows much greater resilience than mine and collaborates far more effectively than in the past.
